SST and familial pancreatic carcinoma: Therefore, before implementing therapy by long-acting somatostatin analogs such as octreotide in pancreatic cancer patients, to make sure that tumor tissue have high affinity somatostatin receptors, it is important to improve efficacy and reduce unnecessary costs.